Share this article
Share this article
ResearchAndMarkets.com s offering.
The concept of lipids has undergone a paradigm shift over the years. Initially, lipids (oils and fats) were considered as all evil and were often blamed to be only a cause of cardiovascular and other chronic diseases. However, with the concept of nutritional lipids, this notion has changed.
Nutritional lipids are the category of lipids that provide health benefits owing to their composition. This study aims to provide an overview of different types of nutritional lipids: omega-3, medium chain triglycerides (MCT), omega-6 (arachidonic acid or ARA), and phytosterols.
Growing consumer awareness regarding the health benefits of nutritional lipids and increasing prevalence of cardiovascular and other lifestyle-related diseases are leading to increasing realization of preventive healthcare approaches by the general population to avoid excessive healthcare expenditure. This is driving the growth of the global nu
Accruent Leads Race to the Cloud With Release of Meridian Cloud for Life Sciences
This highly secure, expertly validated SaaS EDMS propels Life Sciences organizations towards the cloud, facilitating breakthrough innovations and improvements to their bottom line.
News provided by
Share this article
Share this article
AUSTIN, Texas, April 28, 2021 /PRNewswire/ Accruent, the leading provider of solutions to manage the built environment, today announced the release of Meridian Cloud for Life Sciences, a cloud-based, validated version of its electronic document management system (EDMS), Meridian, which 8 out of the world s top 10 pharmaceutical companies already use today.
Learn more about Accruent s powerful validated cloud EDMS solution at https://get.accruent.com/meridian-life-sciences.
/PRNewswire/ Stem Holdings, Inc. d/b/a Driven by Stem (OTCQX: STMH) (CSE: STEM) (the "Company" or "Stem"), the first multi-state, vertically integrated.
CARISMA Therapeutics to Present Data at The American Society of Gene & Cell Therapy 24th Annual Meeting
News provided by
Share this article
Share this article
PHILADELPHIA, April 28, 2021 /PRNewswire/ CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced findings from two studies accepted for virtual presentation at The American Society of Gene & Cell Therapy (ASGCT) 24th Annual Meeting on Tuesday, May 11 – Friday, May 14. The findings mark the first time chimeric antigen receptor macrophages (CAR-Ms) have been assessed in a fully immunocompetent animal model and highlight the potential of CAR-monocytes (CAR-Mono) as an innovative and expedited immunotherapeutic pathway.
Share this article
OAKLAND, Calif., April 28, 2021 /PRNewswire/
Blue Shield of California today announced that it has provided more than $114 million in direct financial support to
244 healthcare providers during the COVID-19 pandemic. The funds are part of a $200 million Provider Financial Support Program that Blue Shield announced last April.
A nurse from Salinas Valley Memorial Healthcare System educates agricultural workers about COVID-19 The program has been successful in accomplishing what we intended, said Sandra Clarke, chief financial officer and senior vice president for Blue Shield. It has primarily helped small to mid-sized practices and hospitals in our network to rise above the financial turmoil created by the pandemic and meet their cash-flow needs after most elective care was postponed during stay-at-home orders in early 2020. Our members rely on these organizations and independent healthcare providers to get the care they need, and I m happy Blue Shield